
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tumor-Associated Lymphatic Vessels Upregulate PDL1 to Inhibit T-Cell Activation
Lothar C. Dieterich, Kristian Ikenberg, Timur Cetintas, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 118
Lothar C. Dieterich, Kristian Ikenberg, Timur Cetintas, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 118
Showing 26-50 of 118 citing articles:
Lymphatic PD-L1 Expression Restricts Tumor-Specific CD8+ T-cell Responses
Nikola Cousin, Stefan Cap, Manuel Dihr, et al.
Cancer Research (2021) Vol. 81, Iss. 15, pp. 4133-4144
Open Access | Times Cited: 57
Nikola Cousin, Stefan Cap, Manuel Dihr, et al.
Cancer Research (2021) Vol. 81, Iss. 15, pp. 4133-4144
Open Access | Times Cited: 57
PD-L1 signaling selectively regulates T cell lymphatic transendothelial migration
Wenji Piao, Lushen Li, Vikas Saxena, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 41
Wenji Piao, Lushen Li, Vikas Saxena, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 41
Biomechanical control of lymphatic vessel physiology and functions
Véronique Angeli, Hwee Ying Lim
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 9, pp. 1051-1062
Open Access | Times Cited: 29
Véronique Angeli, Hwee Ying Lim
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 9, pp. 1051-1062
Open Access | Times Cited: 29
Lymphatic vessels in the age of cancer immunotherapy
Triantafyllia Karakousi, Tenny Mudianto, Amanda W. Lund
Nature reviews. Cancer (2024) Vol. 24, Iss. 6, pp. 363-381
Closed Access | Times Cited: 14
Triantafyllia Karakousi, Tenny Mudianto, Amanda W. Lund
Nature reviews. Cancer (2024) Vol. 24, Iss. 6, pp. 363-381
Closed Access | Times Cited: 14
Convergent inducers and effectors of T cell paralysis in the tumour microenvironment
Douglas Hanahan, Olivier Michielin, Mikaël J. Pittet
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 9
Douglas Hanahan, Olivier Michielin, Mikaël J. Pittet
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 9
Multiple roles of lymphatic vessels in tumor progression
Qiaoli Ma, Lothar C. Dieterich, Michael Detmar
Current Opinion in Immunology (2018) Vol. 53, pp. 7-12
Open Access | Times Cited: 83
Qiaoli Ma, Lothar C. Dieterich, Michael Detmar
Current Opinion in Immunology (2018) Vol. 53, pp. 7-12
Open Access | Times Cited: 83
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer
Carlotta Tacconi, Federica Ungaro, Carmen Correale, et al.
Cancer Research (2019) Vol. 79, Iss. 16, pp. 4196-4210
Open Access | Times Cited: 73
Carlotta Tacconi, Federica Ungaro, Carmen Correale, et al.
Cancer Research (2019) Vol. 79, Iss. 16, pp. 4196-4210
Open Access | Times Cited: 73
Postpartum Involution and Cancer: An Opportunity for Targeted Breast Cancer Prevention and Treatments?
Virginia F. Borges, Traci R. Lyons, Doris Germain, et al.
Cancer Research (2020) Vol. 80, Iss. 9, pp. 1790-1798
Open Access | Times Cited: 69
Virginia F. Borges, Traci R. Lyons, Doris Germain, et al.
Cancer Research (2020) Vol. 80, Iss. 9, pp. 1790-1798
Open Access | Times Cited: 69
Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs
Christopher Montemagno, Gilles Pagès
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 67
Christopher Montemagno, Gilles Pagès
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 67
Type 1 IFN and PD-L1 Coordinate Lymphatic Endothelial Cell Expansion and Contraction during an Inflammatory Immune Response
Erin D. Lucas, Jeffrey M. Finlon, Matthew A. Burchill, et al.
The Journal of Immunology (2018) Vol. 201, Iss. 6, pp. 1735-1747
Open Access | Times Cited: 62
Erin D. Lucas, Jeffrey M. Finlon, Matthew A. Burchill, et al.
The Journal of Immunology (2018) Vol. 201, Iss. 6, pp. 1735-1747
Open Access | Times Cited: 62
Lymph Node Lymphatic Endothelial Cell Expansion and Contraction and the Programming of the Immune Response
Erin D. Lucas, Beth A. Jirón Tamburini
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 59
Erin D. Lucas, Beth A. Jirón Tamburini
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 59
Human Tumor‐Lymphatic Microfluidic Model Reveals Differential Conditioning of Lymphatic Vessels by Breast Cancer Cells
José M. Ayuso, Max M. Gong, Melissa C. Skala, et al.
Advanced Healthcare Materials (2020) Vol. 9, Iss. 3
Open Access | Times Cited: 58
José M. Ayuso, Max M. Gong, Melissa C. Skala, et al.
Advanced Healthcare Materials (2020) Vol. 9, Iss. 3
Open Access | Times Cited: 58
MHC Class II Antigen Presentation by Lymphatic Endothelial Cells in Tumors Promotes Intratumoral Regulatory T cell–Suppressive Functions
Anastasia O. Gkountidi, Laure Garnier, Juan Dubrot, et al.
Cancer Immunology Research (2021) Vol. 9, Iss. 7, pp. 748-764
Open Access | Times Cited: 53
Anastasia O. Gkountidi, Laure Garnier, Juan Dubrot, et al.
Cancer Immunology Research (2021) Vol. 9, Iss. 7, pp. 748-764
Open Access | Times Cited: 53
The lymphatic system and sentinel lymph nodes: conduit for cancer metastasis
Stanley P. L. Leong, A Pissas, Muriel Scarato, et al.
Clinical & Experimental Metastasis (2021) Vol. 39, Iss. 1, pp. 139-157
Open Access | Times Cited: 50
Stanley P. L. Leong, A Pissas, Muriel Scarato, et al.
Clinical & Experimental Metastasis (2021) Vol. 39, Iss. 1, pp. 139-157
Open Access | Times Cited: 50
IFN-γ–dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis
Laure Garnier, Robert Pick, Julien Montorfani, et al.
Science Advances (2022) Vol. 8, Iss. 23
Open Access | Times Cited: 36
Laure Garnier, Robert Pick, Julien Montorfani, et al.
Science Advances (2022) Vol. 8, Iss. 23
Open Access | Times Cited: 36
Proteomics approaches to characterize the immune responses in cancer
Víctor Urbiola-Salvador, Dominika Miroszewska, Agnieszka Jabłońska, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2022) Vol. 1869, Iss. 8, pp. 119266-119266
Open Access | Times Cited: 32
Víctor Urbiola-Salvador, Dominika Miroszewska, Agnieszka Jabłońska, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2022) Vol. 1869, Iss. 8, pp. 119266-119266
Open Access | Times Cited: 32
Lymph nodes: at the intersection of cancer treatment and progression
Nathan E. Reticker-Flynn, Edgar G. Engleman
Trends in Cell Biology (2023) Vol. 33, Iss. 12, pp. 1021-1034
Open Access | Times Cited: 19
Nathan E. Reticker-Flynn, Edgar G. Engleman
Trends in Cell Biology (2023) Vol. 33, Iss. 12, pp. 1021-1034
Open Access | Times Cited: 19
The emerging importance of lymphatics in health and disease: an NIH workshop report
Babak J. Mehrara, Andrea J. Radtke, Gwendalyn J. Randolph, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 17
Open Access | Times Cited: 19
Babak J. Mehrara, Andrea J. Radtke, Gwendalyn J. Randolph, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 17
Open Access | Times Cited: 19
Role of lymph node stroma and microenvironment in T cell tolerance
Vikas Saxena, Lushen Li, Christina Paluskievicz, et al.
Immunological Reviews (2019) Vol. 292, Iss. 1, pp. 9-23
Open Access | Times Cited: 54
Vikas Saxena, Lushen Li, Christina Paluskievicz, et al.
Immunological Reviews (2019) Vol. 292, Iss. 1, pp. 9-23
Open Access | Times Cited: 54
Immuno-oncology-101: overview of major concepts and translational perspectives
Bertrand Allard, Sandrine Aspeslagh, Soizic Garaud, et al.
Seminars in Cancer Biology (2018) Vol. 52, pp. 1-11
Closed Access | Times Cited: 53
Bertrand Allard, Sandrine Aspeslagh, Soizic Garaud, et al.
Seminars in Cancer Biology (2018) Vol. 52, pp. 1-11
Closed Access | Times Cited: 53
Blockade of the programmed death ligand 1 (PD-L1) as potential therapy for anaplastic thyroid cancer
Silvia Cantara, Eugenio Bertelli, Rossella Occhini, et al.
Endocrine (2019) Vol. 64, Iss. 1, pp. 122-129
Closed Access | Times Cited: 53
Silvia Cantara, Eugenio Bertelli, Rossella Occhini, et al.
Endocrine (2019) Vol. 64, Iss. 1, pp. 122-129
Closed Access | Times Cited: 53
Lymphatics in the liver
Masatake Tanaka, Yasuko Iwakiri
Current Opinion in Immunology (2018) Vol. 53, pp. 137-142
Open Access | Times Cited: 47
Masatake Tanaka, Yasuko Iwakiri
Current Opinion in Immunology (2018) Vol. 53, pp. 137-142
Open Access | Times Cited: 47
Lymphatic Function in Autoimmune Diseases
Noa Schwartz, Madhavi Latha Somaraju Chalasani, Thomas M. Li, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 47
Noa Schwartz, Madhavi Latha Somaraju Chalasani, Thomas M. Li, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 47
The lymphatic vasculature: An active and dynamic player in cancer progression
Sara Rezzola, Elena C. Sigmund, Cornelia Halin, et al.
Medicinal Research Reviews (2021) Vol. 42, Iss. 1, pp. 576-614
Open Access | Times Cited: 35
Sara Rezzola, Elena C. Sigmund, Cornelia Halin, et al.
Medicinal Research Reviews (2021) Vol. 42, Iss. 1, pp. 576-614
Open Access | Times Cited: 35
Mechanisms and Clinical Significance of Tumor Lymphatic Invasion
Noriki Fujimoto, Lothar C. Dieterich
Cells (2021) Vol. 10, Iss. 10, pp. 2585-2585
Open Access | Times Cited: 34
Noriki Fujimoto, Lothar C. Dieterich
Cells (2021) Vol. 10, Iss. 10, pp. 2585-2585
Open Access | Times Cited: 34